- CHEN M, Chen W, Jiang X, Liang S, et al
Virtual screening targeting the conserved domain of the IAV M2 protein reveals the potential broad-spectrum anti-IAV activity of ajmaline.
Biochem Biophys Res Commun. 2026;814:153643.
PubMed Abstract available - DAVIES SR, Davies AL, Higgins JPT, Caldwell DM, et al
Effectiveness of interventions to increase vaccine uptake: component network meta-analysis.
BMJ. 2026;393:e087578.
PubMed Abstract available - HWANG CS, Lu Z, Russo M, Zakoul H, et al
Physician Awareness of FDA's Relaxation of REMS-Required Laboratory Testing Requirements and Changes in Prescribing Practices During the COVID-19 Pandemic.
Drug Saf. 2026;49:519-528.
PubMed Abstract available - COATES MM, Rowe SL, Sullivan SG, Munoz FM, et al
Assessing the Use of Medical Insurance Claims and Electronic Health Records to Measure COVID-19 Vaccination During Pregnancy.
Drug Saf. 2026;49:567-580.
PubMed Abstract available - RACHWAL O, Gutierrez-Lobon M, Cueto NS, Ventura AN, et al
Evaluating COVID-19 Vaccine Masking and Unmasking Methods in Two National Pharmacovigilance Databases.
Drug Saf. 2026;49:581-590.
PubMed Abstract available - JAJOU R, van Puijenbroek E, Overbeek J, Hek K, et al
GP Consultations for Herpes Zoster After COVID-19 Vaccination: A Self-Controlled Cohort Study Based on Electronic Health Record Data from the Netherlands.
Drug Saf. 2026;49:529-539.
PubMed Abstract available - GONZALES BE, Ochoa TJ, van der Sande MAB
Inequalities in complete pneumococcal vaccination among Peruvian children before and after the COVID-19 pandemic: An evaluation using demographic and health surveys from 2018 to 2023.
Epidemiol Infect. 2026;154:e49.
PubMed Abstract available - KIMURA M, Asai Y, Tsuzuki S, Shimizu Y, et al
Effectiveness of voluntary PCR testing against COVID-19 spread in remote Japanese islands.
Epidemiol Infect. 2026;154:e48.
PubMed Abstract available - ASGHARI M, Golalipour M, Memarian A, Farazmandfar T, et al
Presentation of multiple copies of a non-dominant surface epitope by circular RNA effectively induce an immune response against SARS-CoV-2.
J Virol Methods. 2026;343:115378.
PubMed Abstract available - CHIBA S
Therapeutic mechanisms of early oseltamivir administration in the management of mild COVID-19 through the sympathetic nervous system: A scoping review.
J Virol Methods. 2026;343:115386.
PubMed Abstract available - JOHANSEN ND, Seco JP, Martinon-Torres F, Biering-Sorensen T, et al
Unclear benefits of higher doses of influenza vaccine - Authors' reply.
Lancet. 2026;407:1426.
PubMed - FLAHAULT A
Unclear benefits of higher doses of influenza vaccine.
Lancet. 2026;407:1425-1426.
PubMed - SOLA I, Zuniga S
New transcription signals in SARS-CoV-2 reshape virus-host interactions.
PLoS Biol. 2026;24:e3003744.
PubMed Abstract available - JEONG YD, Hart WS, Ishikane M, Kim KS, et al
Identifying the optimal rapid antigen test for screening and determining the end of isolation: A modeling study.
PLoS Comput Biol. 2026;22:e1013102.
PubMed Abstract available - ANOKYE F, Li MWZ, Walker S, Hurford A, et al
Quantifying SARS-CoV-2 Omicron variant spread and the impact of non-pharmaceutical interventions in Newfoundland and Labrador, Canada.
PLoS Comput Biol. 2026;22:e1013562.
PubMed Abstract available - ABDELGHANY M, Yu F, Rennard S, Gwon Y, et al
Bayesian reanalysis of early remdesivir for the treatment of COVID-19 in outpatients with high risk of progression to severe disease.
PLoS One. 2026;21:e0346878.
PubMed Abstract available - BERBER E, Hanley HB, Gamez BM, Ross TM, et al
Assessment of hemagglutinin-inhibition activity following influenza vaccination during the 2022-2023, 2023-2024, and 2024-2025 seasons.
PLoS One. 2026;21:e0347314.
PubMed Abstract available - MURALIDHAR K, Ngaybe MGB, Pope B, Nanjaiah S, et al
Behavioural and Social Drivers (BeSD) of COVID-19 vaccination for children: A cross-sectional study of parental vaccine confidence and intent in Mysore, India.
PLoS One. 2026;21:e0316877.
PubMed Abstract available - BHUPATHI M, Hegde S, Molloy JC, Devarapu GCR, et al
MobileLAMP: A low-cost, portable incubation device for isothermal nucleic acid amplification.
PLoS One. 2026;21:e0346874.
PubMed Abstract available - SHIMAZU Y, Isoda N, Hiono T, Hew YL, et al
Evaluation of therapeutic efficacy of baloxavir marboxil against high pathogenicity avian influenza virus infection in duck model.
PLoS One. 2026;21:e0347205.
PubMed Abstract available - GANGAT R, Ngah V, Tawonga R, Blanford JI, et al
Spatial and temporal patterns of SARS-CoV-2 infection in uMgungundlovu, KwaZulu-Natal, South Africa.
PLoS One. 2026;21:e0317648.
PubMed Abstract available - VAN DUINKERKEN A, van der Velden PG, Duckers MLA, Baliatsas C, et al
Revisiting the exposure criterion for PTSD: Using the COVID-19 pandemic as an opportunity to assess measurement invariance of PTSD symptoms across event types.
PLoS One. 2026;21:e0347315.
PubMed Abstract available - KITTUR ME, Jones BDM, Imran S, Wang W, et al
Impact of the COVID-19 pandemic on adults accessing specialist psychiatric care: A cross-sectional Canadian analysis.
PLoS One. 2026;21:e0346913.
PubMed Abstract available - CASJENS S, Hovanec J, Glaser N, Massag J, et al
Occupational risk factors for depression and anxiety symptoms: Insights from a large cohort study during and after the SARS-CoV-2 pandemic.
PLoS One. 2026;21:e0346871.
PubMed Abstract available - JIANG KP, Bennett S, Yager P
Heat-actuated valve implementation in a point-of-care, paper-based microfluidic device for infectious disease detection.
PLoS One. 2026;21:e0344750.
PubMed Abstract available - ABBAS U, Laghari RN, Ahmed I, Musawwir UA, et al
Acute SARS-CoV-2 viral load and systemic inflammation are associated with neuropsychiatric and musculoskeletal symptoms in long COVID.
PLoS One. 2026;21:e0346978.
PubMed Abstract available - OZATO N, Hori S, Miyai N, Takase H, et al
Association of visceral fat and plasmacytoid dendritic cell-derived interferon alpha with SARS-CoV-2 infection.
PLoS One. 2026;21:e0344870.
PubMed Abstract available - DIAS GF, Fan C, Han M, Wang X, et al
COVID-19 in hemodialysis patients: New insights into metabolomic profile dynamics from 60 days pre- to 60 days post-diagnosis.
PLoS One. 2026;21:e0346687.
PubMed Abstract available - MOHTASHAM F, Hashemi Nazari SS, Pourhoseingholi MA, Kavousi K, et al
Hybrid feature-selection and diversity-guided stacking framework for interpretable ensemble learning: Application to COVID-19 mortality prediction.
PLoS One. 2026;21:e0341198.
PubMed Abstract available - LEE SJ, Kim J, Han M, Lee JA, et al
Distinct plasma cytokine and chemokine profiles in severe COVID-19 and septic shock.
PLoS One. 2026;21:e0347126.
PubMed Abstract available - GOLDMAN N, Pebley AR
The Latino health experience: Past and future.
Proc Natl Acad Sci U S A. 2026;123:e2530795123.
PubMed Abstract available - HUOT M, Wang D, Shakhnovich E, Monasson R, et al
Constrained evolutionary funnels shape viral immune escape.
Proc Natl Acad Sci U S A. 2026;123:e2536956123.
PubMed Abstract available - FARIAS A, Bridgeman VL, Rodrigues FS, Puttur F, et al
Type I interferons induced upon respiratory viral infection impair lung metastatic initiation.
Proc Natl Acad Sci U S A. 2026;123:e2412919123.
PubMed Abstract available - HSIEH SM, Choi MJ, Chen YC, Cheng SY, et al
Cost-effectiveness of vaccination of older adults with an MF59(R)-adjuvanted quadrivalent influenza vaccine compared to standard-dose and high-dose vaccines in South Korea and Taiwan.
Vaccine. 2026;80:128533.
PubMed Abstract available - ANYALECHI EG, Marquez PL, Rubin MN, Johannsen SP, et al
Safety of seasonal inactivated influenza vaccines in children 6 months-17 years of age in the Vaccine Adverse Events Reporting System (VAERS) 2018-2023: before, during, and after the COVID-19 pandemic public health emergency.
Vaccine. 2026;81:128569.
PubMed Abstract available - SWIERKOT J, Tyczynska KM, Siemaszko J, Madej M, et al
The association of selected genetic polymorphisms with adverse events following COVID-19 vaccination: a single-centre prospective observational cohort study.
Virology. 2026;619:110876.
PubMed Abstract available - CHEN G, Liang D, Liu M, Lv Z, et al
Theaflavins suppresses RSV infection by modulating the MAVS-I-IFN pathway.
Virology. 2026;619:110872.
PubMed Abstract available - LIU R, Patterson L, Yeasmin M, Kim KH, et al
Low-dose multivalent COVID-19 mRNA vaccines enhance broadly cross-reactive antibodies and protective immune responses of co-administered protein-based vaccines.
Virology. 2026;619:110884.
PubMed Abstract available - WANG Z, Wongnak R, Oba M, Mizutani T, et al
Omicron RBD expressed in E. coli outperforms mammalian-expressed S1 spike protein in generating highly neutralizing anti-SARS-CoV-2 antibodies in mice.
Virology. 2026;619:110894.
PubMed Abstract available - RICHARDSON SAS, Boodhoo N, Bhat S, Wells J, et al
Differential outcomes of viral co-infections with high pathogenicity avian influenza A(H5N6) and SARS-CoV-2 in mammalian in vitro systems.
Virology. 2026;620:110912.
PubMed Abstract available
Biochem Biophys Res Commun
No comments:
Post a Comment